Main Session
Sep
28
SS 12 - Small Cell Lung Cancer and Thymic Malignancies
155 - Post-Chemoradiotherapy Molecular Residual Disease (MRD) Clearance Determines Long-Term Survival in Limited-Stage Small Cell Lung Cancer: A Prospective Longitudinal Study
Presenter(s)
Yaru Tian, - Shandong Cancer Hospital and Institute, Jinan,